)
)
)
Megan Dover
Co-Founder & Partner
,
Cross Border Impact Ventures
Megan Dover, Co-founder & Partner of Cross Border Impact Ventures (CBIV), has in depth experience in impact investing, angel investing, venture advisory, M&A, business strategy and Financial Planning & Analysis. At CBIV, she invests in Series A stage disruptive health technology companies in North America and Europe that address unmet health needs for women and children globally. Prior to the launch of the firm, she was a venture partner to a portfolio of impact first health technology companies and mobilized $46 million in equity and non dilutive capital for the portfolio. Megan obtained her MBA from the Rotman School of Management at the University of Toronto and her Biomedical Engineering degree with Honours from Queen's University.